Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 2OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Breast Neoplasms 3Recurrence 2Ovarian Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Carcinoma, Non-Small-Cell Lung 2Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lung Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hodgkin Disease 1Glioblastoma 1Eye Neoplasms 1Carcinoma, Transitional Cell 1Adenocarcinoma 1

Interventions

Cyclophosphamide 48fludarabine phosphate 32Peripheral Blood Stem Cell Transplantation 32Whole-Body Irradiation 26Etoposide 23Mycophenolic Acid 22Rituximab 20Filgrastim 18Doxorubicin 18Vincristine 16Cyclosporine 16Busulfan 16Tacrolimus 15Prednisone 15Methotrexate 13Melphalan 13Antilymphocyte Serum 12Cytarabine 11Radiotherapy 10Carboplatin 10Bortezomib 9romidepsin 8Ifosfamide 8Cord Blood Stem Cell Transplantation 8Methylprednisolone 7Lenalidomide 7Flow Cytometry 7Brentuximab Vedotin 7Sirolimus 6Everolimus 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoma, Large-Cell, Anaplastic × belinostat × Clear all
NCT01686165 2018-08-28

Belinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Aggressive B-Cell NHL

University of Arizona

Phase 2 Completed
5 enrolled 8 charts
Lymphoid

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡